120 related articles for article (PubMed ID: 1391670)
1. Moving from the question of efficacy to the question of therapeutic relevance: an exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam.
Herrmann WM; Stephan K
Int Psychogeriatr; 1992; 4(1):25-44. PubMed ID: 1391670
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of vincamine in dementia.
Fischhof PK; Möslinger-Gehmayr R; Herrmann WM; Friedmann A; Russmann DL
Neuropsychobiology; 1996; 34(1):29-35. PubMed ID: 8884757
[TBL] [Abstract][Full Text] [Related]
3. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of xantinolnicotinate in patients with dementia.
Kanowski S; Fischhof PK; Grobe-Einsler R; Wagner G; Litschauer G
Pharmacopsychiatry; 1990 May; 23(3):118-24. PubMed ID: 2197635
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM
Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039
[TBL] [Abstract][Full Text] [Related]
6. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
Kanowski S; Hoerr R
Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
[TBL] [Abstract][Full Text] [Related]
7. EEG mapping and psychopharmacological studies with denbufylline in SDAT and MID.
Saletu B; Anderer P; Fischhof PK; Lorenz H; Barousch R; Böhmer F
Biol Psychiatry; 1992 Oct; 32(8):668-81. PubMed ID: 1457622
[TBL] [Abstract][Full Text] [Related]
8. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R
Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021
[TBL] [Abstract][Full Text] [Related]
9. Confirmed clinical efficacy of Actovegin in elderly patients with organic brain syndrome.
Kanowski S; Kinzler E; Lehmann E; Schweizer A; Kuntz G
Pharmacopsychiatry; 1995 Jul; 28(4):125-33. PubMed ID: 7491366
[TBL] [Abstract][Full Text] [Related]
10. EEG brain mapping in diagnostic and therapeutic assessment of dementia.
Saletu B; Anderer P; Paulus E; Grünberger J; Wicke L; Neuhold A; Fischhof PK; Litschauer G
Alzheimer Dis Assoc Disord; 1991; 5 Suppl 1():S57-75. PubMed ID: 1781975
[TBL] [Abstract][Full Text] [Related]
11. European Pentoxifylline Multi-Infarct Dementia Study.
Eur Neurol; 1996; 36(5):315-21. PubMed ID: 8864715
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of brief infusions with Ginkgo biloba Special Extract EGb 761 in dementia of the vascular and Alzheimer type].
Haase J; Halama P; Hörr R
Z Gerontol Geriatr; 1996; 29(4):302-9. PubMed ID: 8974721
[TBL] [Abstract][Full Text] [Related]
13. A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia.
Herrmann WM; Stephan K; Gaede K; Apeceche M
Dement Geriatr Cogn Disord; 1997; 8(1):9-17. PubMed ID: 8997547
[TBL] [Abstract][Full Text] [Related]
14. Retrospective estimate of the nursing cost of autonomy impairment and cost benefit in clinical trials: feasibility and application of piracetam in demented elderly patients.
Vlietinck R; Van Loon H; Van de Broele H; Tormans G
Adv Ther; 1993; 10(5):226-44. PubMed ID: 10172000
[TBL] [Abstract][Full Text] [Related]
15. The GBS scale in multi-infarct dementia and senile dementia of Alzheimer type.
Olafsson K; Kørner A; Bille A; Jensen HV; Thiesen S; Andersen J
Acta Psychiatr Scand; 1989 Jan; 79(1):94-7. PubMed ID: 2929386
[TBL] [Abstract][Full Text] [Related]
16. Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study.
Görtelmeyer R; Erbler H
Arzneimittelforschung; 1992 Jul; 42(7):904-13. PubMed ID: 1418054
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of organic brain syndrome with nicergoline given once a day].
Ladurner G; Erhart P; Erhart C; Scheiber V
Wien Klin Wochenschr; 1991; 103(1):8-14. PubMed ID: 2014712
[TBL] [Abstract][Full Text] [Related]
18. Auditory and visual event-related potentials in patients suffering from Alzheimer's dementia and multiinfarct dementia, before and after treatment with piracetam.
Dabic-Jeftic M; Mikula I
Funct Neurol; 1993; 8(5):335-45. PubMed ID: 8144060
[TBL] [Abstract][Full Text] [Related]
19. Piracetam for dementia or cognitive impairment.
Flicker L; Grimley Evans G
Cochrane Database Syst Rev; 2001; (2):CD001011. PubMed ID: 11405971
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and clinical relevance of cognition enhancers.
Herrmann WM; Stephan K
Alzheimer Dis Assoc Disord; 1991; 5 Suppl 1():S7-12. PubMed ID: 1781976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
